Christopher G. Slatore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher G. Slatore has a total of 278 co-authors. Here are the top co-authors by number of shared publications:
- Renda Soylemez Wiener
Center for Health Optimization & Implementation Research, VA Boston Healthcare System, Boston, MA, United States
25 shared publications David H. Au
Health Service Research and Development, VA Puget Sound Health Care System, Seattle, Washington; and
21 shared publications- Sara E. Golden
VA Portland Health Care System
20 shared publications - Donald Richard Sullivan
Oregon Health & Science University , Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine; Center to Improve Veteran Involvement in Care (CIVIC) VA Portland Health Care System
11 shared publications Linda Ganzini
Center to Improve Veteran Involvement in Care and
10 shared publicationsEmily White
Fred Hutchinson Cancer Research Center, Cancer Prevention Program, Seattle, WA, USA
9 shared publications
Latest Publications
- 6 March 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (11) , 2740-2753
Resistance to Switching Health Care Institution Among Veterans Referred for VA-Purchased Care
Background Little is known about how Veterans choose between receiving Veterans Affairs (VA)–paid health care from VA-direct care (care provided in VA facilities) vs. non-VA facilities (VA-purchased care). Objective To evaluate Veterans’ resistance to switch their hypothetical choice of health care institution with reasonable alterations in quality and access using Discrete Choice Experiments (DCE). Design We conducted a nationwide survey among Veterans who had been offered a referral for VA-purchased care. Participants Of the 12,547 Veterans we approached, 1253 (10.0%) respondents had evaluable data. Main Measures We summarized DCE results. We evaluated the multi-variable adjusted association of travel time to the nearest VA facility (≤ 1 h vs. > 1 h) with resistance to switch health care institutions. We calculated predicted probabilities (PP) for resistance to switching and separately based on distrust in VA health care. Key Results When respondents imagined their local VA facility was 1 h farther away than their local VA-purchased care facility, more than 60% chose VA-direct care for every quality and access improvement scenario (e.g., VA had higher quality of care). However, when all factors of care in both institutions were equal, up to 60% of respondents who initially chose VA-purchased care would not switch to VA-direct care for any incremental improvement in access and quality of VA-direct care. Travel time was not associated with high resistance to switching health care location (adjusted OR 1.1, 95% CI 0.8–1.4; p = .70). Respondents who originally chose VA-purchased care and had high distrust in VA had the highest predicted probabilities of resistance to switch (≤ 1 h travel time: PP 36%, CI 28–43%; > 1 h travel time: PP 42%, CI 34–49%). Conclusions Interventions to increase Veterans choosing VA-direct care should improve Veterans’ understanding of VA and non-VA quality and access and also improve trust in VA.
- 6 March 2025
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 40 (11) , 2740-2753
Resistance to Switching Health Care Institution Among Veterans Referred for VA-Purchased Care
Background Little is known about how Veterans choose between receiving Veterans Affairs (VA)–paid health care from VA-direct care (care provided in VA facilities) vs. non-VA facilities (VA-purchased care). Objective To evaluate Veterans’ resistance to switch their hypothetical choice of health care institution with reasonable alterations in quality and access using Discrete Choice Experiments (DCE). Design We conducted a nationwide survey among Veterans who had been offered a referral for VA-purchased care. Participants Of the 12,547 Veterans we approached, 1253 (10.0%) respondents had evaluable data. Main Measures We summarized DCE results. We evaluated the multi-variable adjusted association of travel time to the nearest VA facility (≤ 1 h vs. > 1 h) with resistance to switch health care institutions. We calculated predicted probabilities (PP) for resistance to switching and separately based on distrust in VA health care. Key Results When respondents imagined their local VA facility was 1 h farther away than their local VA-purchased care facility, more than 60% chose VA-direct care for every quality and access improvement scenario (e.g., VA had higher quality of care). However, when all factors of care in both institutions were equal, up to 60% of respondents who initially chose VA-purchased care would not switch to VA-direct care for any incremental improvement in access and quality of VA-direct care. Travel time was not associated with high resistance to switching health care location (adjusted OR 1.1, 95% CI 0.8–1.4; p = .70). Respondents who originally chose VA-purchased care and had high distrust in VA had the highest predicted probabilities of resistance to switch (≤ 1 h travel time: PP 36%, CI 28–43%; > 1 h travel time: PP 42%, CI 34–49%). Conclusions Interventions to increase Veterans choosing VA-direct care should improve Veterans’ understanding of VA and non-VA quality and access and also improve trust in VA.
- Open Access
- 4 March 2025
- Published by Elsevier in CHEST Pulmonary
- Vol. 3 (2)
Association of Communication With Smoking Attitudes and Behaviors Among Patients Undergoing Lung Cancer Screening
- 4 March 2025
- Published by Elsevier in CHEST Pulmonary
- Vol. 3 (2)
Open AccessAssociation of Communication With Smoking Attitudes and Behaviors Among Patients Undergoing Lung Cancer Screening
- Open Access
- 17 January 2025
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 10 (1)
Associations of Concordant and Shared Lung Cancer Screening Decision Making with Decisional Conflict: A Multi-Institution Cross-Sectional Analysis
Introduction. Many organizations recommend structured communication processes, including formal shared decision making (SDM), for patients undergoing lung cancer screening (LCS) using low-dose computed tomography (LDCT). We sought to understand if concordant and shared LCS decision making was associated with decisional conflict. Methods. In this prospective, observational study, we enrolled patients from 3 medical centers (2 Veterans Health Administration, 1 academic facility) after a decision-making interaction about undergoing LCS but before receiving the LDCT. We included patients who indicated they accepted or declined to undergo the LDCT. We evaluated preferred and actual decision-making roles and used multivariable linear and logistic regression models to measure the association of concordant (congruence between actual and preferred roles) and shared LCS decision making with decisional conflict to report adjusted odds ratios (AOR). Results. Of the 409 participants with nonmissing information, 83% reported LCS decision-making role concordance. In addition, 223 (58%) reported an indeterminate level and 56 (14%) reported decisional conflict. LCS decision-making role concordance was not associated with decisional conflict (AOR = 0.86, 95% confidence interval [CI]: 0.38–1.94, P = 0.71) compared with role discordance. Participant-reported actual LCS SDM role was not associated with decisional conflict (AOR = 0.99, 95% CI: 0.51–1.93, P = 0.98) compared with patient- or provider-controlled roles. Conclusions. LCS decisional conflict was uncommon, although many patients reported an indeterminate level of decisional conflict. Neither concordant nor shared LCS decision-making role was associated with decisional conflict. Clinicians may be unable to decrease LCS decisional conflict using efforts to enhance decision-making interactions. Highlights: We evaluated patients’ preferred and actual decision-making role and decisional conflict following a decision-making interaction about lung cancer screening (LCS). Concordant decision-making preference was not associated with decisional conflict. Actual decision-making role was also not associated with decisional conflict. Efforts to enhance decision-making interactions may not decrease LCS decisional conflict.
- 17 January 2025
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 10 (1)
Open AccessAssociations of Concordant and Shared Lung Cancer Screening Decision Making with Decisional Conflict: A Multi-Institution Cross-Sectional Analysis
Introduction. Many organizations recommend structured communication processes, including formal shared decision making (SDM), for patients undergoing lung cancer screening (LCS) using low-dose computed tomography (LDCT). We sought to understand if concordant and shared LCS decision making was associated with decisional conflict. Methods. In this prospective, observational study, we enrolled patients from 3 medical centers (2 Veterans Health Administration, 1 academic facility) after a decision-making interaction about undergoing LCS but before receiving the LDCT. We included patients who indicated they accepted or declined to undergo the LDCT. We evaluated preferred and actual decision-making roles and used multivariable linear and logistic regression models to measure the association of concordant (congruence between actual and preferred roles) and shared LCS decision making with decisional conflict to report adjusted odds ratios (AOR). Results. Of the 409 participants with nonmissing information, 83% reported LCS decision-making role concordance. In addition, 223 (58%) reported an indeterminate level and 56 (14%) reported decisional conflict. LCS decision-making role concordance was not associated with decisional conflict (AOR = 0.86, 95% confidence interval [CI]: 0.38–1.94, P = 0.71) compared with role discordance. Participant-reported actual LCS SDM role was not associated with decisional conflict (AOR = 0.99, 95% CI: 0.51–1.93, P = 0.98) compared with patient- or provider-controlled roles. Conclusions. LCS decisional conflict was uncommon, although many patients reported an indeterminate level of decisional conflict. Neither concordant nor shared LCS decision-making role was associated with decisional conflict. Clinicians may be unable to decrease LCS decisional conflict using efforts to enhance decision-making interactions. Highlights: We evaluated patients’ preferred and actual decision-making role and decisional conflict following a decision-making interaction about lung cancer screening (LCS). Concordant decision-making preference was not associated with decisional conflict. Actual decision-making role was also not associated with decisional conflict. Efforts to enhance decision-making interactions may not decrease LCS decisional conflict.
- 21 September 2024
- Published by Elsevier in Preventive Medicine
- Vol. 189, 108142
“I've been really happy since I got that letter!”: Longitudinal patient perspectives on lung cancer screening communication
- 21 September 2024
- Published by Elsevier in Preventive Medicine
- Vol. 189, 108142
“I've been really happy since I got that letter!”: Longitudinal patient perspectives on lung cancer screening communication
Longitudinal Assessment of Communication With Patient-Reported Outcomes During Lung Cancer Screening
- Open Access
- 1 July 2024
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 9 (2)
Is Lung Cancer Screening Knowledge Associated with Patient-Centered Outcomes? A Multi-institutional Cohort Study
Introduction. The Centers for Medicare and Medicaid Services mandate that clinicians use a shared decision-making interaction to provide information about the harms and benefits of lung cancer screening (LCS). Methods. We enrolled patients from 3 geographically diverse medical centers after a decision-making interaction about undergoing LCS but before receiving a low-dose computed tomography (CT) scan. We performed the primary analysis based on the primary knowledge question, “Which of these conditions do you think that the CT scan screens for?” We used the knowledge summary score in secondary analyses. We evaluated LCS care experience by using validated instruments to measure participant-reported communication quality (Consultation Care Measure), perception of the primary LCS clinician (Consumer Assessment of Health Care Providers and Systems), and decision conflict (Decisional Conflict Scale). Results. Of the 409 participants, 44% correctly answered the primary LCS knowledge question. Clinician communication quality was rated positively by 93% of participants. Most (93%) participants rated their LCS clinician as good. Only 14% reported decision conflict. Correctly answering the primary LCS knowledge question was associated with higher patient-clinician communication quality scores (b = 0.4; 95% confidence interval [CI] [0.1, 0.7]; R2 change = 0.03) and higher LCS clinician ratings (b = 0.4; 95% CI [0.0, 0.7]; R2 change = 0.02) but not with decision conflict. In secondary analyses, higher total LCS knowledge score was associated with lower Decisional Conflict Scale scores (b = −2.2; 95% CI [−3.4, −0.9]; R2 change = 0.24), indicating lower decision conflict. Conclusions. After an LCS decision-making interaction, many patients do not retain basic knowledge about LCS but nevertheless had low levels of decision conflict. Primary LCS knowledge may be important but insufficient to ensure high-quality, patient-centered LCS care. Highlights: Survey of patients with a lung cancer screening (LCS) decision-making interaction. Only 44% of patients correctly answered the knowledge question about LCS. Primary LCS knowledge was not associated with decision conflict. Patient knowledge about LCS may not equate to high-quality patient-centered care.
- 1 July 2024
- Published by SAGE Publications in MDM Policy & Practice
- Vol. 9 (2)
Open AccessIs Lung Cancer Screening Knowledge Associated with Patient-Centered Outcomes? A Multi-institutional Cohort Study
Introduction. The Centers for Medicare and Medicaid Services mandate that clinicians use a shared decision-making interaction to provide information about the harms and benefits of lung cancer screening (LCS). Methods. We enrolled patients from 3 geographically diverse medical centers after a decision-making interaction about undergoing LCS but before receiving a low-dose computed tomography (CT) scan. We performed the primary analysis based on the primary knowledge question, “Which of these conditions do you think that the CT scan screens for?” We used the knowledge summary score in secondary analyses. We evaluated LCS care experience by using validated instruments to measure participant-reported communication quality (Consultation Care Measure), perception of the primary LCS clinician (Consumer Assessment of Health Care Providers and Systems), and decision conflict (Decisional Conflict Scale). Results. Of the 409 participants, 44% correctly answered the primary LCS knowledge question. Clinician communication quality was rated positively by 93% of participants. Most (93%) participants rated their LCS clinician as good. Only 14% reported decision conflict. Correctly answering the primary LCS knowledge question was associated with higher patient-clinician communication quality scores (b = 0.4; 95% confidence interval [CI] [0.1, 0.7]; R2 change = 0.03) and higher LCS clinician ratings (b = 0.4; 95% CI [0.0, 0.7]; R2 change = 0.02) but not with decision conflict. In secondary analyses, higher total LCS knowledge score was associated with lower Decisional Conflict Scale scores (b = −2.2; 95% CI [−3.4, −0.9]; R2 change = 0.24), indicating lower decision conflict. Conclusions. After an LCS decision-making interaction, many patients do not retain basic knowledge about LCS but nevertheless had low levels of decision conflict. Primary LCS knowledge may be important but insufficient to ensure high-quality, patient-centered LCS care. Highlights: Survey of patients with a lung cancer screening (LCS) decision-making interaction. Only 44% of patients correctly answered the knowledge question about LCS. Primary LCS knowledge was not associated with decision conflict. Patient knowledge about LCS may not equate to high-quality patient-centered care.
- 29 February 2024
- Published by Elsevier in Lung Cancer
- Vol. 190, 107526
Association of patient and health care organization factors with incidental nodule guidelines adherence: A multi-system observational study
- 29 February 2024
- Published by Elsevier in Lung Cancer
- Vol. 190, 107526
Association of patient and health care organization factors with incidental nodule guidelines adherence: A multi-system observational study
- 15 January 2024
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 209 (2) , 197-205
What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening
Rationale: Achieving the net benefit of lung cancer screening (LCS) depends on optimizing patient selection. Objective: To identify factors associated with clinician assessments that a patient was unlikely to benefit from LCS (“LCS-inappropriate”) because of comorbidities or limited life expectancy. Methods: Retrospective analysis of patients assessed for LCS at 30 Veterans Health Administration facilities from January 1, 2015 to February 1, 2021. We conducted hierarchical mixed-effects logistic regression analyses to determine factors associated with clinicians’ designations of LCS inappropriateness (primary outcome), accounting for 3-year predicted probability (i.e., competing risk) of non–lung cancer death. Measurements and Main Results: Among 38,487 LCS-eligible patients, 1,671 (4.3%) were deemed LCS-inappropriate by clinicians, whereas 4,383 (11.4%) had an estimated 3-year competing risk of non–lung cancer death greater than 20%. Patients with higher competing risks of non–lung cancer death were more likely to be deemed LCS-inappropriate (odds ratio [OR], 2.66; 95% confidence interval [CI], 2.32–3.05). Older patients (ages 75–80; OR, 1.45; 95% CI, 1.18–1.78) and those with interstitial lung disease (OR, 1.98; 95% CI, 1.51–2.59) were more likely to be deemed LCS-inappropriate than would be explained by competing risk of non–lung cancer death, whereas patients currently smoking (OR, 0.65; 95% CI, 0.58–0.73) were less likely to be deemed LCS-inappropriate, suggesting that clinicians over- or underweighted these factors. The probability of being deemed LCS-inappropriate varied from 0.4% to 74%, depending on the clinician making the assessment (median OR, 3.07; 95% CI, 2.89–3.25). Conclusion: Concerningly, the likelihood that a patient is deemed LCS-inappropriate is more strongly associated with the clinician making the assessment than with patient characteristics. Patient selection may be optimized by providing decision support to help clinicians assess net LCS benefit.
- 15 January 2024
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 209 (2) , 197-205
What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening
Rationale: Achieving the net benefit of lung cancer screening (LCS) depends on optimizing patient selection. Objective: To identify factors associated with clinician assessments that a patient was unlikely to benefit from LCS (“LCS-inappropriate”) because of comorbidities or limited life expectancy. Methods: Retrospective analysis of patients assessed for LCS at 30 Veterans Health Administration facilities from January 1, 2015 to February 1, 2021. We conducted hierarchical mixed-effects logistic regression analyses to determine factors associated with clinicians’ designations of LCS inappropriateness (primary outcome), accounting for 3-year predicted probability (i.e., competing risk) of non–lung cancer death. Measurements and Main Results: Among 38,487 LCS-eligible patients, 1,671 (4.3%) were deemed LCS-inappropriate by clinicians, whereas 4,383 (11.4%) had an estimated 3-year competing risk of non–lung cancer death greater than 20%. Patients with higher competing risks of non–lung cancer death were more likely to be deemed LCS-inappropriate (odds ratio [OR], 2.66; 95% confidence interval [CI], 2.32–3.05). Older patients (ages 75–80; OR, 1.45; 95% CI, 1.18–1.78) and those with interstitial lung disease (OR, 1.98; 95% CI, 1.51–2.59) were more likely to be deemed LCS-inappropriate than would be explained by competing risk of non–lung cancer death, whereas patients currently smoking (OR, 0.65; 95% CI, 0.58–0.73) were less likely to be deemed LCS-inappropriate, suggesting that clinicians over- or underweighted these factors. The probability of being deemed LCS-inappropriate varied from 0.4% to 74%, depending on the clinician making the assessment (median OR, 3.07; 95% CI, 2.89–3.25). Conclusion: Concerningly, the likelihood that a patient is deemed LCS-inappropriate is more strongly associated with the clinician making the assessment than with patient characteristics. Patient selection may be optimized by providing decision support to help clinicians assess net LCS benefit.